Pentostatin, as a specific ADA inhibitor, decreases the catalytic activity in control fibroblasts (** p = 0.0059) and IPF fibroblasts (** p = 0.0014). The gene discussed is ADA; the disease is idiopathic pulmonary fibrosis.